HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 241 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2022. The put-call ratio across all filers is 1.21 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $594,022 | -3.8% | 18,127 | +3.3% | 0.00% | 0.0% |
| Q2 2023 | $617,409 | +30.1% | 17,545 | +20.7% | 0.00% | +33.3% |
| Q1 2023 | $474,470 | -40.6% | 14,532 | +0.3% | 0.00% | -50.0% |
| Q4 2022 | $798,619 | +23.4% | 14,494 | -0.8% | 0.01% | +20.0% |
| Q3 2022 | $647,000 | -5.0% | 14,609 | +4.6% | 0.01% | 0.0% |
| Q2 2022 | $681,000 | +6.4% | 13,971 | +6.3% | 0.01% | +25.0% |
| Q1 2022 | $640,000 | +7.6% | 13,149 | -5.8% | 0.00% | +33.3% |
| Q4 2021 | $595,000 | +26.9% | 13,955 | +14.1% | 0.00% | 0.0% |
| Q3 2021 | $469,000 | +32.5% | 12,234 | -2.3% | 0.00% | +200.0% |
| Q2 2021 | $354,000 | +195.0% | 12,525 | +246.0% | 0.00% | – |
| Q1 2021 | $120,000 | -8.4% | 3,620 | +0.3% | 0.00% | – |
| Q4 2020 | $131,000 | – | 3,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |